Compounds > gemcitabine
Page last updated: 2024-08-24

gemcitabine and Leukemia P388

gemcitabine has been researched along with Leukemia P388 in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (66.67)18.2507
2000's2 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahmad, I; Ahmad, MU; Ali, SM; Chen, P; Chien, PY; Khan, AR; Sheikh, S1
Amenitsch, H; Bourgaux, C; Couvreur, P; Desmaële, D; Lepêtre-Mouelhi, S; Mangenot, S; Ollivon, M; Pili, B; Poupaert, JH; Reddy, LH1
Gilbert, KS; Grindey, GB; Waud, WR; Worzalla, JF1
Marańda, E; Robak, T1
Marañda, E; Robak, T; Szmigielska, A1
Boder, GB; Grindey, GB; Hertel, LW; Kroin, JS; Poore, GA; Rinzel, SM; Todd, GC1

Other Studies

6 other study(ies) available for gemcitabine and Leukemia P388

ArticleYear
In-vitro and in-vivo anti-cancer activity of a novel gemcitabine-cardiolipin conjugate.
    Anti-cancer drugs, 2006, Volume: 17, Issue:1

    Topics: Animals; Antineoplastic Agents; Body Weight; Cardiolipins; Cell Proliferation; Deoxycytidine; Dipyridamole; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Gemcitabine; HT29 Cells; Humans; Leukemia P388; Leukocyte Count; Mice; Mice, SCID; Neutropenia; Nucleoside Transport Proteins; Pancreatic Neoplasms; Thioinosine; Xenograft Model Antitumor Assays

2006
Discovery of new hexagonal supramolecular nanostructures formed by squalenoylation of an anticancer nucleoside analogue.
    Small (Weinheim an der Bergstrasse, Germany), 2008, Volume: 4, Issue:2

    Topics: Animals; Antineoplastic Agents; Cryoelectron Microscopy; Deoxycytidine; Gemcitabine; Leukemia P388; Macromolecular Substances; Mice; Mice, Inbred DBA; Models, Molecular; Nanostructures; Nanotechnology; Scattering, Small Angle; Squalene; X-Ray Diffraction

2008
Lack of in vivo crossresistance with gemcitabine against drug-resistant murine P388 leukemias.
    Cancer chemotherapy and pharmacology, 1996, Volume: 38, Issue:2

    Topics: Animals; Antimetabolites, Antineoplastic; Cell Survival; Deoxycytidine; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Gemcitabine; Leukemia P388; Mice; Molecular Structure

1996
Interactions of 2',2'-diflurodeoxycytidine (gemcitabine) with tumor necrosis factor alpha or its mutein VI in murine leukemias L1210 and P388.
    Archivum immunologiae et therapiae experimentalis, 1998, Volume: 46, Issue:2

    Topics: Animals; Antimetabolites, Antineoplastic; Deoxycytidine; Drug Interactions; Gemcitabine; Leukemia L1210; Leukemia P388; Male; Mice; Tumor Necrosis Factor-alpha

1998
Additive action of gemcitabine (2',2'-difluorodeoxycytidine) and 2-chlorodeoxyadenosine on murine leukemias L1210 and P388.
    Cancer investigation, 1999, Volume: 17, Issue:2

    Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Deoxycytidine; Drug Administration Schedule; Drug Screening Assays, Antitumor; Drug Synergism; Gemcitabine; Leukemia L1210; Leukemia P388; Male; Mice

1999
Evaluation of the antitumor activity of gemcitabine (2',2'-difluoro-2'-deoxycytidine).
    Cancer research, 1990, Jul-15, Volume: 50, Issue:14

    Topics: Animals; Antimetabolites, Antineoplastic; Cell Line; Cell Survival; Deoxycytidine; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Female; Flow Cytometry; Gemcitabine; Humans; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Male; Mice; Mice, Inbred ICR; Mice, Inbred Strains; Neoplasms, Experimental; Tumor Cells, Cultured

1990